Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking. We aimed to clarify the outcomes of repeated MPA...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gynecol Oncol
Autori principali: Yamagami, Wataru, Susumu, Nobuyuki, Makabe, Takeshi, Sakai, Kensuke, Nomura, Hiroyuki, Kataoka, Fumio, Hirasawa, Akira, Banno, Kouji, Aoki, Daisuke
Natura: Artigo
Lingua:Inglês
Pubblicazione: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5823982/
https://ncbi.nlm.nih.gov/pubmed/29400014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e21
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi